Icon Advisers Inc Exelixis, Inc. Transaction History

Icon Advisers Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 03, 2018	SELL	$18.56 - $22.45 $1.38 Million - $1.66 Million	-74,149 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$24.23 - $30.93 $1.02 Million - $1.3 Million	42,149 Added 131.72%	74,149 $2.25 Million
Q3 2017 Nov 08, 2017	BUY	$23.35 - $29.24 $747,200 - $935,680	32,000	32,000 $775,000

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Icon Advisers Inc with notifications on news.